Thursday - December 04, 2025

Category Archives: Marketing & Sales

Prostate Cancer Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen R&D

The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals, Point Biopharma, AstraZeneca, Essa Pharma, and others.   DelveInsight’s “Prostate … Continue reading →

Pancreatic Cancer Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co

The Key Pancreatic Cancer Companies in the market include – AstraZeneca, Merck Sharp & Dohme, Actuate Therapeutics, Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co.Ltd, Carisma Therapeutics Inc, Cue Biopharma, Bold Therapeutics, Purple Biotech Ltd, ENB Therapeutics, … Continue reading →

Custom Bottle Sourcing Guide: Types, Sizes, Shapes, Colors, and Manufacturing Processes

Custom Bottle Sourcing Guide: Types, Sizes, Shapes, Colors, and Manufacturing Processes For liquor brands, distilleries, glass bottle distributors, and spirits packaging distributors, choosing the right custom bottles is a strategic purchasing decision that impacts brand positioning, cost-effectiveness, and supply chain … Continue reading →

Liver Cancer Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Eli Lilly, Merck, Genetech, GlaxoSmithKline, Bristol-Myers Squibb

The Key Liver Cancer Companies in the market include – Eli Lilly, Merck, Genetech, GlaxoSmithKline, Bristol-Myers Squibb, and others.   DelveInsight’s “Liver Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Liver Cancer, historical and … Continue reading →

Lymphatic Malformations Market Expected to Experience Major Growth by 2034, According to DelveInsight | Venthera and Bridge Bio, Palvella Therapeutics, Zynerba Pharma, Nobias Therapeutics, Inc.

The Key Lymphatic Malformations Companies in the market include – Protara Therapeutics, Palvella Therapeutics, Novartis, Venthera and Bridge Bio, Palvella Therapeutics, Zynerba Pharmaceuticals, Nobias Therapeutics, Inc., Avalo Therapeutics, Inc, and others.   DelveInsight’s “Lymphatic Malformations Market Insights, Epidemiology, and Market … Continue reading →

Antibody Drug Conjugates Market Set to Grow Substantially Through 2034, DelveInsight Projects | Bristol Myers Squibb, GSK, MBrace therapeutics, Oxford Biotherapeutics, Pfizer/Seagen

The Key Antibody Drug Conjugates Companies in the market include – Bristol Myers Squibb, GSK, MBrace therapeutics, Oxford Biotherapeutics, Pfizer/Seagen, Abbvie/ImmunoGen, Adcendo, AdcentrX Therapeutics, Alentis Therapeutics, Araris Biotech, AstraZeneca/Daiichi Sankyo, BioNTech/DualityBio, Roche, Takeda Pharmaceuticals, and others.   DelveInsight’s “Antibody Drug … Continue reading →

Carcinoid Syndrome Market to Expand Significantly by 2034, States DelveInsight Report | Novartis, Ipsen, Lexicon Pharma, Crinetics Pharma

The Key Carcinoid Syndrome Companies in the market include – Ipsen Biopharmaceuticals, Lexicon Pharmaceuticals, Crinetics Pharmaceuticals, Sanwa Kagaku Kenkyusho, Novartis, Ipsen, and others.   DelveInsight’s “Carcinoid Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the … Continue reading →

R/R Acute Myeloid Leukemia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Foghorn Therapeutics, AB Science, Oncoceutics, Sanofi

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Relapsed/Refractory Acute Myeloid Leukemia pipeline constitutes 50+ key companies continuously working towards developing 75+ Relapsed/Refractory Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Non-Small Cell Lung Cancer Market Growth Projections 2024-2034: DelveInsight Analysis | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo

The Key Non-Small Cell Lung Cancer Companies in the market include – Merck, AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Inc., Gilead Sciences, Merck Sharp & Dohme LLC, Arcus Biosciences, Inc., Ono Pharmaceutical … Continue reading →